Effectiveness of the Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea

This study has been completed.
Sponsor:
Information provided by:
Universidade Federal do Piauí
ClinicalTrials.gov Identifier:
NCT01455285
First received: October 11, 2011
Last updated: October 18, 2011
Last verified: May 2011

October 11, 2011
October 18, 2011
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT01455285 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effectiveness of the Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea
Investigation of the Effectiveness of Different Modulations of Pulse Frequency Transcutaneous Electrical Nerve Stimulation in Dysmenorrhea

Hypothesis: What is the best modulation of pulse frequency in transcutaneous electrical nerve stimulation in dysmenorrhea? Purpose: To determine the effect of hypoalgesia frequency modulation pulse by transcutaneous electrical nerve (TENS) in dysmenorrhea. Methods: A controlled clinical study and prospective developed at the School of Physiotherapy Clinic / UFPI. Forty students were randomized into four distinct groups of the modulation frequency TENS: group 1 - 100 Hz, 100μs, group 2 - 4 Hz, 100μs, group 3 - placebo (apparatus off), group 4 - placebo induced (2 Hz, 40μs). All were initially evaluated by a questionnaire developed for the study, the visual analogue scale (VAS) (before, after 20, 30, 40, 50, 60 minutes) and the McGill Pain Questionnaire (before and after 20 minutes). The total duration of TENS application was 20 minutes and all protocols were performed in a single session. The analysis of variance (One-way ANOVA) followed by the Tukey procedure was applied to identify differences between experimental groups for each variable analyzed. The level of significance was p< 0,05.

Not Provided
Interventional
Not Provided
Primary Purpose: Treatment
Dysmenorrhea
Device: transcutaneous electrical nerve stimulation
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
Not Provided
Not Provided

Inclusion Criteria:

  • be the first or second day of menstruation
  • dysmenorrhea present at the time of application of TENS
  • not having undergone any procedure analgesic six hours before the application of TENS

Exclusion Criteria:

  • not to mention dysmenorrhea at the time of evaluation
  • pregnant women
  • were using some method of hormonal contraception on an ongoing basis
  • had sensory deficits or cognitive and cases of contraindication to TENS application.
Female
16 Years to 33 Years
No
Contact information is only displayed when the study is recruiting subjects
Brazil
 
NCT01455285
0377.0.045.000-10
Yes
Not Provided
Universidade Federal do Piauí
Not Provided
Not Provided
Universidade Federal do Piauí
May 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP